Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific ...

There’s been talk about liquid biopsies and the promise of using blood samples to test for a wide variety of cancers at once.

Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG ...

(Alliance News) - Cizzle Biotechnology Holdings PLC on Monday saw its shares surge as it reported that the process of preparing for submission of its CIZ1B test for Clinical Laboratory Improvement ...

You can get at-home medical tests for everything from Covid-19 to drug testing to hormone levels or food sensitivities. You can examine your gut, your blood, or even your DNA. At-home STI tests use ...

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

Jharkhand’s blood banks scarcely organise blood donation camps, lack manpower and adequate testing facilities, records have ...

Explore the evolution of clinical proteomics in modern medicine. Discover how advanced protein analysis transforms biomarker ...

Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has secured a further US$720,000 in non-dilutive funding after completing a key enrolment milestone in its ongoing US paediatric clinical study for ...

University of York spin-out Cizzle Biotechnology has announced a step forward in its bid to launch a new technology for identifying early-stage lung cancer.

Cizzle Biotechnology of York is set for a multi-million dollar boost as it moves towards launching a product to detect lung cancer at an early stage.